BBLG
Bone Biologics Corporation
There isn't enough reported data to score BBLG yet.
BBLG Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Under pressure | |
| Unavailable | |
| Unavailable |
BBLG's profitability is currently under pressure. There isn't enough data to rate its revenue, cash flow and balance sheet.
BBLG PE Valuation
BBLG has no meaningful PE right now: it lost money over the past year.
BBLG Forward outlook
There aren't enough analyst estimates for BBLG to show an outlook.
BBLG Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$1.66 | +$4.84 |
| Q2 2026 | -$1.86 | +$18.49 |
| Q1 2026 | -$2.76 | +$20.28 |
| Q4 2025 | -$4.25 | +$24.73 |
| Q3 2023 | -$283.20 | +$134.40 |
| Q2 2023 | -$426.72 | +$62.88 |
| Q1 2021 | -$3,254.40 | +$7,113.60 |
| Q4 2020 | -$5,385.60 | +$8,150.40 |
BBLG lost $1.66 per share over the past year, a smaller loss than the year before.
BBLG Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q1 2021 | $1.1B | 0% |
| Quarter | Margin | YoY |
|---|---|---|
| Q1 2021 | 0% | 0 points |
| Q1 2020 | 0% | N/A |
BBLG Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$532.3K | +$59.1K |
| Q2 2026 | -$518.4K | -$59.6K |
| Q1 2026 | -$804.3K | +$121.8K |
| Q4 2025 | -$714.8K | +$638.7K |
| Q3 2025 | -$591.4K | -$19.2K |
| Q2 2025 | -$458.9K | +$437K |
| Q1 2025 | -$926.1K | +$377.3K |
| Q4 2024 | -$1.4M | +$664.5K |
BBLG has burned cash in almost every quarter: −$3M over the past year, against −$3M the year before.
BBLG Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +108% | +1.9M shares |
| 1 year | +570% | +3.2M shares |
| 3 years | +32121% | +3.7M shares |
| 5 years | +1477104% | +3.7M shares |
BBLG has 4M diluted shares, up 570% from a year ago.
BBLG Net Leverage
BBLG's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
BBLG Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 27.8 | Oversold |
| Stochastic | 6.0 | Oversold |
BBLG's weekly RSI is 28 (oversold) and its Stochastic is 6 (oversold).
BBLG PE vs Healthcare Sector
BBLG has no meaningful PE right now: it lost money over the past year.
BBLG Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.42 | 4.8% below |
| 20 week MA | $0.69 | 42% below |
| 50 week MA | $1.13 | 65% below |
| 100 week MA | $2.55 | 84% below |
| 200 week MA | $29.0 | 99% below |
BBLG is in a downtrend: it's below all five of its weekly moving averages, and 99% below its 200-week average.
BBLG Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $3,297.6 | $2,865.6 | -13% |
| 2022 | $2,865.6 | $151.4 | -95% |
| 2023 | $151.4 | $27.1 | -82% |
| 2024 | $27.1 | $5.70 | -79% |
| 2025 | $5.70 | $1.70 | -70% |
| 2026 YTD | $1.70 | $0.40 | -76% |
BBLG has finished every year since 2021 lower, and it's down 76% so far in 2026.